Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: relation to clinical symptoms, liver histopathology and outcome
- 1 May 1992
- journal article
- clinical trial
- Published by Wiley in Journal of Internal Medicine
- Vol. 231 (5) , 485-491
- https://doi.org/10.1111/j.1365-2796.1992.tb00964.x
Abstract
Hyaluronan (HA) and aminoterminal propeptide of type III procollagen (PIIINP), two biochemical connective tissue markers, were determined in 76 patients with primary biliary cirrhosis (PBC). The HA and PIIINP concentrations were significantly increased compared with controls (P less than 0.001). Both HA and PIIINP levels correlated significantly with conventional liver-function tests. All patients with stage IV PBC showed increased concentrations of both these variables. However, HA was a better marker with regard to prediction of development of cirrhosis as well as prediction of symptoms. Furthermore, HA also showed a negative correlation with time of survival (P less than 0.05). The present data indicate that HA is a more sensitive marker of liver damage in PBC than PIIINP.Keywords
This publication has 28 references indexed in Scilit:
- Aminoterminal Propeptide of Type III Procollagen is Cleared from the Circulation by Receptor-Mediated Endocytosis in Liver Endothelial CellsCollagen and Related Research, 1988
- TYPE III PROCOLLAGEN PEPTIDE: A MARKER OF DISEASE ACTIVITY AND PROGNOSIS IN PRIMARY BILIARY CIRRHOSISThe Lancet, 1988
- Serum basement membrane and type III procollagen-related antigens in primary biliary cirrhosisJournal of Hepatology, 1988
- Serum hyaluronate in primary biliary cirrhosis—A biochemical marker for progressive liver damageHepatology, 1988
- The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosisJournal of Hepatology, 1986
- Blood analysis for liver fibrosisJournal of Hepatology, 1985
- Enzymes of collagen synthesis and type III procollagen aminopropeptide in the evaluation of D-penicillamine and medroxyprogesterone treatments of primary biliary cirrhosis.Gut, 1983
- PRIMARY BILIARY CIRRHOSIS—A REVISED CLINICAL SPECTRUMThe Lancet, 1981
- Radioimmunoassay for type III procollagen peptide and its application to human liver diseaseEuropean Journal of Clinical Investigation, 1979
- AN INTRAVENOUS GALACTOSE TOLERANCE TEST AND ITS USE IN HEPATOBILIARY DISEASES1Acta Medica Scandinavica, 1968